Equity · Healthcare
SRPT
NASDAQSarepta Therapeutics (SRPT)
Reddit mentioned SRPT 1 times in the 30 days to 23 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 23 October 2026.
The line runs $16.10 on 27 July through $18.57 on 21 October, on a scale from $10 to $25. Days the market did not trade hold the previous close, flat.
as of Oct 21, 2026
Sarepta Therapeutics (SRPT) · crowd attention × price
Share ↗
Day25 Sep 2026
SRPT drew 1 Reddit mentions over the 30 days to 23 October 2026
SRPT drew 7 Reddit mentions over the 90 days to 23 October 2026
This chart in words
The chart plots daily Reddit mentions of SRPT over the 30 days to 23 October 2026: 1 in total, busiest on 25 September with 1, and 1 on the last day counted. The line is the daily close over the same window: $18.38 on 24 September, $18.57 on 21 October. Of those days, 20 were trading sessions and the other 10 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 2 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.
The chart plots daily Reddit mentions of SRPT over the 90 days to 23 October 2026: 7 in total, busiest on 8 August with 2, and 1 on the last day counted. The line is the daily close over the same window: $16.10 on 27 July, $18.57 on 21 October. Of those days, 62 were trading sessions and the other 28 are hatched on the chart. On 25 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them no session took place, and this window holds no earlier close to carry forward; on 2 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.
Sarepta Therapeutics (SRPT) on Reddit · 30d
In the 30 days to 23 Oct 2026, Sarepta Therapeutics drew 1 Reddit mention in the finance subreddits we track, 1 of them scored for sentiment.
1 mention of SRPT was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.
Where SRPT is discussed
(30d)Sarepta Therapeutics (SRPT) insider trades
In the 90 days to 23 Oct 2026, no Sarepta Therapeutics insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Sarepta Therapeutics (SRPT) reported financials
SEC EDGARSarepta Therapeutics reported revenue of $1.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$713.4M.
Sarepta Therapeutics (SRPT) earnings
Sarepta Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.05; no next date is announced in SEC filings yet.
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
Sarepta Therapeutics (SRPT) institutional holders (13F)
SEC EDGAR9 of the 45 institutional funds we track reported a Sarepta Therapeutics position for the quarter ended 30 Jun 2026 — a combined $262.6M; the latest of those filings landed 02 Sep 2026.
Sarepta Therapeutics (SRPT) fails-to-deliver
SECOn 30 Sep 2026, 1,157 shares of Sarepta Therapeutics failed to deliver (about $22K).
Congressional trades in Sarepta Therapeutics (SRPT)
House disclosuresThe most recent congressional trade disclosed in Sarepta Therapeutics is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 14 Apr 2025.
Sarepta Therapeutics (SRPT): frequently asked questions
Have Sarepta Therapeutics insiders bought or sold shares recently?
In the 90 days to 23 Oct 2026, no Sarepta Therapeutics insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
How many institutions hold Sarepta Therapeutics?
9 of the 45 institutional funds we track reported a Sarepta Therapeutics position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.
Has Sarepta Therapeutics had fails-to-deliver recently?
Yes. The most recent SEC fails-to-deliver record for Sarepta Therapeutics is dated 30 Sep 2026, when 1,157 shares failed to deliver.
When did Sarepta Therapeutics last report earnings?
Sarepta Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.05; no next date is announced in SEC filings yet.
What exchange is Sarepta Therapeutics listed on?
Sarepta Therapeutics trades on NASDAQ under the ticker SRPT.
What is Reddit saying about Sarepta Therapeutics?
Sarepta Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of 1 classified mentions, 0% read bullish, 0% bearish and 100% neutral. Crowd sentiment is a social signal, not investment advice.
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SECSEC fails-to-deliver (CNS) data
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Sarepta_Therapeutics